E-LIB Suche - Ergebnisse für: Velleca, M

1

EE289 Ablation Index in Catheter Ablation of Atrial Fibrill..:

Galvain, T ; Tong, C ; Velleca, M...
Value in Health. 25 (2022) 7 - p. S390 , 2022

Link: https://doi.org/10.1016/..

2

POSA154 A Comparison of the Costs of Atrial Fibrillation Ab..:

Wei, T ; Stabile, G ; Taylor, H...
Value in Health. 25 (2022) 1 - p. S64 , 2022

Link: https://doi.org/10.1016/..

3

PCV54 - ESTIMATED ECONOMIC BURDEN OF ATRIAL FIBRILLATION IN..:

Velleca, M. ; Patel, L. ; Goyert, N...
Value in Health. 21 (2018) - p. S101 , 2018

Link: https://doi.org/10.1016/..

4

Feasibility Assessment: The Impact of A Reduced Operating R..:

Taylor, H ; Zagra, A ; Giudici, F...
Value in Health. 20 (2017) 9 - p. A596-A597 , 2017

Link: https://doi.org/10.1016/..

5

The Economic Impact of Using Antimicrobial Catheters Impreg..:

Mercurio, M ; Paragò, V ; Velleca, M...
Value in Health. 19 (2016) 7 - p. A688-A689 , 2016

Link: https://doi.org/10.1016/..

6

Clinical Impact of Antimicrobial Impregnated Catheters For ..:

Parker, E ; Velleca, M ; Scagliarini, L
Value in Health. 19 (2016) 7 - p. A686 , 2016

Link: https://doi.org/10.1016/..

7

Making Collaborative Relative Effectiveness Assessments Rel..:

Griffin, A ; Hemels, M ; Velleca, M..
Value in Health. 18 (2015) 7 - p. A561 , 2015

Link: https://doi.org/10.1016/..

8

Triclosan Coated Antibacterial Suture: A Budget Impact Anal..:

Velleca, M. ; Socievole, G. ; Muehlendyck, C.
Value in Health. 17 (2014) 7 - p. A668 , 2014

Link: https://doi.org/10.1016/..

9

A Deterministic Model to Evaluate the Costs for Surgical Pr..:

Velleca, M. ; Mauro, E. ; Belarbi, S..
Value in Health. 16 (2013) 7 - p. A468 , 2013

Link: https://doi.org/10.1016/..

10

DRG system in Italy: Evaluation Of Different Reimbursements..:

Velleca, M. ; Petrarca, G. ; Perrone, F.
Value in Health. 16 (2013) 3 - p. A245 , 2013

Link: https://doi.org/10.1016/..

11

StratafixTM Knotless Tissue Control Device: A Budget Impact..:

Perrone, F. ; Muehlendyck, C. ; Velleca, M.
Value in Health. 16 (2013) 7 - p. A559 , 2013

Link: https://doi.org/10.1016/..

12

196 PK/PD models using a selective Ephrin B4 inhibitor JI-1..:

Sharma, S. ; Mullangi, R. ; Wade, M....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 66 , 2010

Link: https://doi.org/10.1016/..

13

400 Phase I study of JI-101, a novel oral tyrosine kinase i..:

Gordon, M. ; Sharma, S. ; Miller, L....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 127 , 2010

Link: https://doi.org/10.1016/..

14

39 Discovery and development of multiplex angiogenesis inhi..:

Qian, D. ; Srinivasa, S. ; Mitchell, S....
European Journal of Cancer Supplements. 2 (2004) 8 - p. 15-16 , 2004

Link: https://doi.org/10.1016/..

15

Molecular cloning and tissue distribution of PHAS-I, an int..:

Hu, C ; Pang, S ; Kong, X..
Proceedings of the National Academy of Sciences. 91 (1994) 9 - p. 3730-3734 , 1994

Link: https://doi.org/10.1073/..